357 related articles for article (PubMed ID: 14963678)
1. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
Kaden JJ; Vocke DC; Fischer CS; Grobholz R; Brueckmann M; Vahl CF; Hagl S; Haase KK; Dempfle CE; Borggrefe M
Z Kardiol; 2004 Feb; 93(2):124-30. PubMed ID: 14963678
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis.
Kaden JJ; Dempfle CE; Grobholz R; Fischer CS; Vocke DC; Kiliç R; Sarikoç A; Piñol R; Hagl S; Lang S; Brueckmann M; Borggrefe M
Cardiovasc Pathol; 2005; 14(2):80-7. PubMed ID: 15780799
[TBL] [Abstract][Full Text] [Related]
3. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
[TBL] [Abstract][Full Text] [Related]
4. Influence of receptor activator of nuclear factor kappa B on human aortic valve myofibroblasts.
Kaden JJ; Dempfle CE; Kiliç R; Sarikoç A; Hagl S; Lang S; Brueckmann M; Borggrefe M
Exp Mol Pathol; 2005 Feb; 78(1):36-40. PubMed ID: 15596058
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
Wilton E; Bland M; Thompson M; Jahangiri M
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
[TBL] [Abstract][Full Text] [Related]
8. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
Kaden JJ; Bickelhaupt S; Grobholz R; Vahl CF; Hagl S; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
J Heart Valve Dis; 2004 Jul; 13(4):560-6. PubMed ID: 15311861
[TBL] [Abstract][Full Text] [Related]
9. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
Dreger SA; Taylor PM; Allen SP; Yacoub MH
J Heart Valve Dis; 2002 Nov; 11(6):875-80; discussion 880. PubMed ID: 12479292
[TBL] [Abstract][Full Text] [Related]
10. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
Inaki N; Tsunezuka Y; Kawakami K; Sato H; Takino T; Oda M; Watanabe G
J Heart Lung Transplant; 2004 Feb; 23(2):218-27. PubMed ID: 14761770
[TBL] [Abstract][Full Text] [Related]
11. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
[TBL] [Abstract][Full Text] [Related]
12. Tissue microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta.
Koullias GJ; Korkolis DP; Ravichandran P; Psyrri A; Hatzaras I; Elefteriades JA
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1098-103. PubMed ID: 15541969
[TBL] [Abstract][Full Text] [Related]
13. Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves.
Bossé Y; Miqdad A; Fournier D; Pépin A; Pibarot P; Mathieu P
Circ Cardiovasc Genet; 2009 Oct; 2(5):489-98. PubMed ID: 20031625
[TBL] [Abstract][Full Text] [Related]
14. Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis.
Satta J; Oiva J; Salo T; Eriksen H; Ohtonen P; Biancari F; Juvonen TS; Soini Y
Ann Thorac Surg; 2003 Sep; 76(3):681-8; discussion 688. PubMed ID: 12963177
[TBL] [Abstract][Full Text] [Related]
15. Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves.
Togashi M; Tamura K; Nitta T; Ishizaki M; Sugisaki Y; Fukuda Y
Pathol Int; 2007 May; 57(5):251-9. PubMed ID: 17493172
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.
LeMaire SA; Wang X; Wilks JA; Carter SA; Wen S; Won T; Leonardelli D; Anand G; Conklin LD; Wang XL; Thompson RW; Coselli JS
J Surg Res; 2005 Jan; 123(1):40-8. PubMed ID: 15652949
[TBL] [Abstract][Full Text] [Related]
17. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
[TBL] [Abstract][Full Text] [Related]
18. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses.
Syggelos SA; Eleftheriou SC; Giannopoulou E; Panagiotopoulos E; Aletras AJ
J Rheumatol; 2001 Jun; 28(6):1319-29. PubMed ID: 11409126
[TBL] [Abstract][Full Text] [Related]
19. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults.
Zegdi R; Ciobotaru V; Noghin M; Sleilaty G; Lafont A; Latrémouille C; Deloche A; Fabiani JN
J Am Coll Cardiol; 2008 Feb; 51(5):579-84. PubMed ID: 18237689
[TBL] [Abstract][Full Text] [Related]
20. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR
Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
